Get the Stockscreener App
2.48
3.77%
0.09
After Hours:
2.48
Annovis Bio Inc stock is traded at $2.48, with a volume of 313.15K.
It is up +3.77% in the last 24 hours and down -10.47% over the past month.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
See More
Previous Close:
$2.39
Open:
$2.4
24h Volume:
313.15K
Relative Volume:
1.01
Market Cap:
$48.33M
Revenue:
-
Net Income/Loss:
$-30.26M
P/E Ratio:
-1.2157
EPS:
-2.04
Net Cash Flow:
$-24.69M
1W Performance:
+8.30%
1M Performance:
-10.47%
6M Performance:
+45.88%
1Y Performance:
-70.72%
1-Day Range:
$2.3631
$2.52
1-Week Range:
$2.26
$2.52
52-Week Range:
$1.11
$10.54
Annovis Bio Inc Stock (ANVS) Company Profile
Name
Annovis Bio Inc
Sector
Industry
Phone
484-875-3192
Address
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Compare ANVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.48 | 45.01M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Downgrade | D. Boral Capital | Buy → Hold |
| Oct-25-24 | Upgrade | Maxim Group | Hold → Buy |
| Dec-29-23 | Initiated | Canaccord Genuity | Buy |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
Annovis Bio Inc Stock (ANVS) Latest News
Annovis Bio’s Promising Alzheimer’s Study: What Investors Need to Know - MSN
Annovis (ANVS) Secures Patent Coverage for Both Forms of Buntanetap - MSN
Annovis Bio CEO to Present at H.C. Wainwright Global Investment Conference - MSN
Annovis Bio Inc. Moves Into Bullish Territory Based on MACDJuly 2025 Review & Verified Entry Point Signals - beatles.ru
Trend Dashboard Flags Annovis Bio Inc. As Potential Swing TradeJuly 2025 Review & Daily Profit Focused Screening - beatles.ru
Can Annovis Bio Inc. disrupt its industry2025 Technical Overview & Stock Portfolio Risk Control - beatles.ru
Chartists See Breakout Potential in Annovis Bio Inc.2025 Volatility Report & Daily Technical Forecast Reports - beatles.ru
Quant Funds Rotate Into Annovis Bio Inc. StockJuly 2025 Highlights & Proven Capital Preservation Tips - beatles.ru
Annovis Bio Advances Phase 3 Alzheimer’s Trial Amid Steady Financial Progress - MSN
How to forecast Annovis Bio Inc. trends using time seriesQuarterly Trade Summary & Daily Volume Surge Trade Alerts - Newser
Is Annovis Bio Inc. impacted by rising ratesTrade Analysis Report & Weekly Watchlist of Top Performers - خودرو بانک
Annovis Bio Inc. recovery potential after sell offPortfolio Performance Report & Long-Term Capital Growth Strategies - Newser
Risk adjusted return profile for Annovis Bio Inc. analyzedJuly 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
Will Annovis Bio Inc. bounce back from current supportTrade Volume Summary & Free Fast Entry Momentum Trade Alerts - Newser
Forecasting Annovis Bio Inc. price range with options dataJuly 2025 Retail & Growth Focused Stock Reports - Newser
Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio - MSN
Analyzing drawdowns of Annovis Bio Inc. with statistical tools2025 Year in Review & Expert-Curated Trade Recommendations - Newser
How to escape a deep drawdown in Annovis Bio Inc.2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - Newser
What makes Annovis Bio Inc. stock attractive todayMarket Movement Recap & AI Optimized Trade Strategies - 강소기업뉴스
Technical analysis overview for Annovis Bio Inc. stockIndex Update & Fast Entry High Yield Stock Tips - Newser
What MACD and RSI say about Annovis Bio Inc.2025 Major Catalysts & Verified High Yield Trade Plans - Newser
Has Annovis Bio Inc. formed a bullish divergenceWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
Regression analysis insights on Annovis Bio Inc. performanceJuly 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Annovis Bio Inc. stock outlook for YEAR2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
How sensitive is Annovis Bio Inc. to inflation2025 Stock Rankings & Verified Momentum Stock Ideas - خودرو بانک
Market Outlook: Does Annovis Bio Inc. stock have upside surprise potential2025 Geopolitical Influence & Advanced Technical Signal Analysis - خودرو بانک
Real time breakdown of Annovis Bio Inc. stock performanceJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - Newser
Price action breakdown for Annovis Bio Inc.Earnings Trend Report & Weekly Return Optimization Alerts - Newser
Best data tools to analyze Annovis Bio Inc. stock2025 Key Highlights & Smart Swing Trading Alerts - Newser
H.C. Wainwright lowers Annovis Bio stock price target to $10 on extended approval timeline By Investing.com - Investing.com Australia
Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
H.C. Wainwright lowers Annovis Bio stock price target to $10 on extended approval timeline - Investing.com
Annovis Bio: HC Wainwright Maintains Buy, PT Down to $10 from $12 - AInvest
Annovis Bio price target lowered to $10 from $12 at H.C. Wainwright - TipRanks
Strategies to average down on Annovis Bio Inc.July 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
What candlestick patterns are forming on Annovis Bio Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - Newser
What is the dividend yield of Annovis Bio Inc.2025 Support & Resistance & Entry Point Strategy Guides - خودرو بانک
What’s the profit margin of Annovis Bio Inc.July 2025 Technicals & Real-Time Buy Zone Alerts - خودرو بانک
Risk vs reward if holding onto Annovis Bio Inc.July 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Annovis Bio Inc Stock (ANVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):